Aro Biotherapeutics rakes in $13 mln

Philadelphia-based Aro Biotherapeutics, a new biotech company, has raised $13 million in funding. The investors were Johnson & Johnson Innovation – JJDC Inc and BioMotiv LLC.

Source: Press Release